France · Question · Question écrite
15895
Question 15895 — pharmacy and medications
Introduced
—
Last action
—
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
—
Summary
Mr. Olivier Gaillard draws the attention of the Minister of Solidarity and Health to the difficulties linked to the marketing of the drug Sativex in France. Marketed in 18 European countries, Sativex, the first cannabis-based medicine authorized on the French market in 2014, is still not sold in pharmacies. This treatment is indicated to alleviate spasticity disorders (inability to walk, pick up objects, etc.) moderate to severe in patients with multiple sclerosis. These disorders are very common and have a real impact on the professional and personal lives of patients. This treatment aims to reduce their suffering but also contributes to human dignity. Many requests come from patients suffering from spastic disorders to have access to this medication. If French regulations prohibited until 2013, the use of cannabis derivatives including when it comes to medicines containing them, Decree No. 2013-473 of June 5, 2013 lifted this ban and opened the way to the use of cannabis-based medicines for therapeutic purposes. In January 2014, marketing authorization for Sativex was granted. However, this drug, offered as a treatment in 18 European countries and 22 countries around the world, is still not not marketed in France. The cause of such a situation would be linked to the impossibility of defining a definitive decision on the reimbursement price of this medicine. Minimizing suffering must be a priority, he would like to know the progress of the marketing procedure for Sativex in France, which would allow many patients suffering from multiple sclerosis to relieve their suffering.
Machine translation from French. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/15/questions/QANR5L15QE15895
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L15QE15895